BRPI0607561A2 - composições antifungo compreendendo sertaconazol e hidrocortisona e/ou um composto quinolona antibacterial - Google Patents

composições antifungo compreendendo sertaconazol e hidrocortisona e/ou um composto quinolona antibacterial

Info

Publication number
BRPI0607561A2
BRPI0607561A2 BRPI0607561-4A BRPI0607561A BRPI0607561A2 BR PI0607561 A2 BRPI0607561 A2 BR PI0607561A2 BR PI0607561 A BRPI0607561 A BR PI0607561A BR PI0607561 A2 BRPI0607561 A2 BR PI0607561A2
Authority
BR
Brazil
Prior art keywords
hydrocortisone
sertaconazole
quinolone compound
mixtures
antifungal compositions
Prior art date
Application number
BRPI0607561-4A
Other languages
English (en)
Inventor
Celia Palacin
Marta Guerrero
Manuel M Raga
Antonio Guglietta
Jesus Torres
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of BRPI0607561A2 publication Critical patent/BRPI0607561A2/pt

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J1/00—Details of electrodes, of magnetic control means, of screens, or of the mounting or spacing thereof, common to two or more basic types of discharge tubes or lamps
    • H01J1/02—Main electrodes
    • H01J1/30—Cold cathodes, e.g. field-emissive cathode

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Manufacturing & Machinery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

COMPOSIçõES ANTIFUNGO COMPREENDENDO SERTACONAZOL E HIDROCORTISONA E/OU UM COMPOSTO QUINOLONA ANTIBACTERIAL. A presente invenção refere-se a composições farmacêuticas úteis para tratamento de doenças dérmicas causadas por fungos e leveduras com inflamação e/ou associadas com uma infecção bacterial. Tais composições contêm uma quantidade terapeuticamente eficaz de sertaconazol, ou um sal, solvato, isómero ou misturas farmaceuticamente eficazes do mesmo; e uma quantidade terapeuticamente eficaz de pelo menos um composto selecionado do grupo consistindo em hidrocortisona, um éster farmaceuticamente aceitável de hidrocortisona, um composto quinolona bactericida e misturas do mesmo.
BRPI0607561-4A 2005-03-01 2006-02-22 composições antifungo compreendendo sertaconazol e hidrocortisona e/ou um composto quinolona antibacterial BRPI0607561A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05101540A EP1698336A1 (en) 2005-03-01 2005-03-01 Antifungal compositions comprising Sertaconazole and either Hydrocortisone or an antibacterial agent
PCT/EP2006/060190 WO2006092374A1 (en) 2005-03-01 2006-02-22 Antifungal compositions comprising sertaconazol and hydrocortisone and/or an antibacterial quinolone compound

Publications (1)

Publication Number Publication Date
BRPI0607561A2 true BRPI0607561A2 (pt) 2009-09-15

Family

ID=34938848

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0607561-4A BRPI0607561A2 (pt) 2005-03-01 2006-02-22 composições antifungo compreendendo sertaconazol e hidrocortisona e/ou um composto quinolona antibacterial

Country Status (16)

Country Link
US (1) US20080166398A1 (pt)
EP (2) EP1698336A1 (pt)
JP (1) JP2008531640A (pt)
KR (1) KR20070107806A (pt)
CN (1) CN101137362A (pt)
AR (1) AR053688A1 (pt)
AU (1) AU2006219903A1 (pt)
BR (1) BRPI0607561A2 (pt)
CA (1) CA2598598A1 (pt)
MX (1) MX2007010703A (pt)
NO (1) NO20074945L (pt)
PE (1) PE20061241A1 (pt)
RU (1) RU2007136169A (pt)
TW (1) TW200640452A (pt)
UY (1) UY29402A1 (pt)
WO (1) WO2006092374A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8057433B2 (en) 2004-07-08 2011-11-15 Drugtech Corporation Delivery system
US20110212933A1 (en) * 2008-03-20 2011-09-01 Allan Shapiro Antiseptic Compositions for the Treatment of Infections
EP2177208A1 (en) 2008-10-17 2010-04-21 Ferrer Internacional, S.A. Pharmaceutical topical compositions
RU2440108C2 (ru) * 2009-11-12 2012-01-20 Общество с ограниченной ответственностью "ШТАДА ФармДевелопмент" Фармацевтическая композиция для лечения аллергических и воспалительных заболеваний кожи
CN103156862B (zh) * 2013-03-28 2015-04-29 孙国栋 一种复方伏立康唑滴耳剂及其制备方法
EP3257512A4 (en) * 2015-02-13 2018-07-25 Maruho Co., Ltd. External preparation comprising pyridonecarboxylic acid derivative
KR20190026686A (ko) * 2016-07-08 2019-03-13 아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이 벤지다민을 포함하는 약학적 조성물
CN113520993B (zh) * 2021-07-30 2022-07-29 海南海神同洲制药有限公司 一种低粘度硝酸舍他康唑乳膏的制备方法及其制备的产品

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407663A (en) * 1991-04-11 1995-04-18 Eisen; Drore Method of treating inflammatory conditions of the mouth using steroid containing mouthwash which may contain antifungal agents
US5578315A (en) * 1993-12-01 1996-11-26 Rutgers, The State University Of New Jersey Mucosal adhesive device for long-acting delivery of pharmaceutical combinations in oral cavity
ATE342897T1 (de) * 1998-04-06 2006-11-15 Toyama Chemical Co Ltd Chinoloncarbonsäurederivate oder deren salze
NZ531404A (en) * 2001-09-04 2006-03-31 Trommsdorff Gmbh & Co Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole
US20030091540A1 (en) * 2001-10-16 2003-05-15 Nawaz Ahmad Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity
ES2203316B1 (es) * 2002-02-11 2005-03-01 Ferrer Internacional, S.A. R-(-)-1-(2-(7-cloro-benzo(b)tiofen-3-il-metoxi)-2-(2,4-dicloro-fenil)-etil)1h-imidazol.
AU2003302305A1 (en) * 2002-12-31 2004-07-22 Sachin S Bhagwat Benzoquinolizine-2-carboxylic acid-containing compositions
DK2106805T3 (da) * 2003-03-21 2011-08-15 Nexmed Holdings Inc Antifungal neglelak og anvendelsesmetode

Also Published As

Publication number Publication date
EP1698336A1 (en) 2006-09-06
JP2008531640A (ja) 2008-08-14
MX2007010703A (es) 2007-10-12
AR053688A1 (es) 2007-05-16
CA2598598A1 (en) 2006-09-08
WO2006092374A1 (en) 2006-09-08
US20080166398A1 (en) 2008-07-10
EP1858510A1 (en) 2007-11-28
UY29402A1 (es) 2006-06-30
RU2007136169A (ru) 2009-04-10
AU2006219903A1 (en) 2006-09-08
KR20070107806A (ko) 2007-11-07
CN101137362A (zh) 2008-03-05
TW200640452A (en) 2006-12-01
NO20074945L (no) 2007-11-21
PE20061241A1 (es) 2006-11-13

Similar Documents

Publication Publication Date Title
WO2020083971A3 (en) New anthelmintic compounds
DK2164331T3 (da) Borholdige små molekyler
CL2020002891A1 (es) Nuevos derivados de quinolina
AR059688A1 (es) Uso de alfa - toxina para tratar y prevenir las infecciones por staphylococcus
BR112018009911A2 (pt) composto, composição, e, métodos para inibir acc, para tratar uma infecção fúngica, parasítica ou bacteriana e para controlar patógenos fúngicos agrícolas.
BR112018010113A2 (pt) composto, composição, e, métodos para inibir acc, para tratar uma infecção fúngica, parasítica ou bacteriana e para controlar patógenos fúngicos agrícolas
MX2009013469A (es) Insecticidas de isoxazolina.
WO2010115184A3 (en) Hydroxythienoquinolones and related compounds as anti-infective agents
WO2007023507A3 (en) Oxazolidinones bearing antimicrobial activity composition and methods of preparation
BR112013025275A2 (pt) derivados de cefalosporina e suas composições farmacêuticas
WO2008023248A3 (en) Novel macrolides and ketolides having antimicrobial activity
BRPI0618479A2 (pt) pirrolpiridinas composição farmacêutica que as contém
TW200734344A (en) Antibacterial agents
WO2008016300A3 (en) Antibiotic composition
FI3886852T3 (fi) Oktyyligallaatti ja sen estereitä käytettäväksi Bacillus megateriumin aiheuttaman ikään liittyvän silmänpohjan rappeuman hoidossa ja ehkäisyssä
NO20074945L (no) Antifungal sammensetning omfattende sertaconalzol og hydrokortison og/eller en antibakteriell kinolinforbindelse
BRPI0916885B8 (pt) composição farmacêutica
WO2007138112A3 (en) Compounds that interact with ion channels, in particular with ion channels from the kv family
MX385203B (es) Compuestos y métodos para tratar infecciones bacterianas.
WO2005070945A8 (ja) メチシリン耐性黄色ブドウ球菌（ｍｒｓａ）に有効な新規アミノグリコシド系抗生物質
WO2008014108A3 (en) Antimicrobial oxazolidinone prodrugs
AR064152A1 (es) Derivados de quinolina antibacterianos,composiciones farmaceuticas que los contienen y metodo de preparacion.
WO2006120563A3 (en) Antibacterial agents
BRPI0511119A (pt) tratamento de doenças associadas com o uso de antibióticos
WO2010036000A3 (en) Novel oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]